Nexus Letter for Hypertension Secondary to Sleep Apnea: Mechanism and Evidence (2026)

Why OSA Causes Hypertension

The clinical relationship between obstructive sleep apnea and hypertension has been recognized for decades and is one of the most extensively studied relationships in cardiovascular medicine. The American Heart Association and American College of Cardiology guidelines specifically identify OSA as a secondary cause of hypertension to be considered in patients with new, severe, or treatment-resistant hypertension. Population studies consistently demonstrate that patients with moderate-to-severe OSA have substantially elevated risk of developing hypertension compared to those without OSA, even after adjusting for body mass index, age, and other cardiovascular risk factors.

For veterans with service-connected OSA, this clinical relationship provides a strong evidentiary foundation for a secondary hypertension claim. The challenge is articulating the specific mechanism in language that the VA rater can match to the regulatory framework.

Pathophysiologic Mechanism

Several interconnected mechanisms link OSA to hypertension. A well-constructed nexus letter typically references all of them.

Intermittent Hypoxia and Sympathetic Activation

Each apneic event produces a transient drop in blood oxygen saturation. The brainstem responds by activating the sympathetic nervous system, producing surges of norepinephrine and epinephrine. These surges raise heart rate, peripheral vascular resistance, and blood pressure during sleep. Over time, the sympathetic nervous system becomes chronically hyperactive, and sympathetic tone remains elevated even during waking hours.

Repeated Arousals and Sleep Fragmentation

OSA produces frequent micro-arousals as the brain responds to airway obstruction. These arousals fragment sleep, prevent deep slow-wave sleep, and elevate cortisol and other stress hormones. The cumulative effect is a chronically dysregulated stress response that contributes to vascular dysfunction.

Endothelial Dysfunction

Repeated cycles of hypoxia and reoxygenation produce oxidative stress in vascular endothelial cells. This impairs nitric-oxide-mediated vasodilation, increases inflammatory markers, and contributes to vascular stiffness — all of which raise blood pressure.

Renin-Angiotensin-Aldosterone System Activation

Chronic intermittent hypoxia activates the renin-angiotensin-aldosterone system (RAAS). RAAS activation leads to fluid retention, increased peripheral vascular resistance, and elevated blood pressure. This is one reason patients with OSA-driven hypertension often require multiple antihypertensive medications and may have a non-dipping blood pressure pattern (failure of normal nighttime blood pressure decline).

Vascular Remodeling

Sustained sympathetic and RAAS activation over years produces structural changes in the arterial wall — smooth muscle hypertrophy, increased collagen deposition, and reduced compliance. These structural changes establish persistent hypertension that is difficult to reverse even when the underlying OSA is treated.

Diagnosing Hypertension Under VA Criteria

The VA uses specific diagnostic criteria for hypertension under 38 CFR 4.104, DC 7101. The diagnosis requires blood pressure readings two or more times on at least three different days. A single elevated reading or "white coat" elevations are not sufficient.

Office Readings

Sequential office blood pressure readings — typically by a primary care or cardiology provider — are the most common documentation. Each visit should record systolic and diastolic measurements, and the pattern over time should be available.

Home Monitoring and Ambulatory Blood Pressure Monitoring

Home blood pressure monitoring with a validated cuff or ambulatory blood pressure monitoring (a 24-hour wearable measuring blood pressure throughout the day) can supplement office readings. Ambulatory monitoring is particularly useful in patients with OSA because it reveals the non-dipping pattern characteristic of the OSA-hypertension relationship.

Medication Requirement

Under DC 7101, hypertension can qualify for a 10 percent rating based on a history of diastolic blood pressure 100 or more requiring continuous medication for control, even when current readings on medication are within normal range. Treatment with antihypertensive medication does not eliminate the rating — the rating is based on the underlying disease, not on whether it is currently controlled.

Rating Under DC 7101

Hypertension is rated under 38 CFR 4.104, Diagnostic Code 7101.

10 Percent

Diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more, or history of diastolic pressure predominantly 100 or more requiring continuous medication for control.

20 Percent

Diastolic pressure predominantly 110 or more, or systolic pressure predominantly 200 or more.

40 Percent

Diastolic pressure predominantly 120 or more.

60 Percent

Diastolic pressure predominantly 130 or more.

The 10 percent rating is the most commonly applied because most veterans with OSA-related hypertension have their blood pressure controlled to normal or near-normal ranges with medication. The history-of-elevated-readings criterion preserves the rating even when current readings on medication are normal.

Temporal Relationship and CPAP Use

The temporal relationship between OSA and hypertension is an important component of the nexus analysis.

Hypertension After OSA Diagnosis

The strongest temporal pattern is hypertension developing after OSA was diagnosed (or after OSA symptoms began but before formal diagnosis). The medical reasoning is that years of untreated nighttime apneas produced the cardiovascular changes that led to hypertension.

Hypertension Before OSA Diagnosis

When hypertension was diagnosed before OSA was formally identified, the nexus opinion may address the likelihood that OSA was already present (often for years) but undiagnosed, with the hypertension reflecting the cumulative effect of the underlying sleep-disordered breathing.

CPAP Use and Treatment Response

CPAP therapy is the standard treatment for moderate-to-severe OSA. CPAP can reduce blood pressure in some patients, but residual hypertension typically persists due to the structural vascular changes that have already occurred. Importantly, the use of CPAP does not eliminate the secondary service connection — the hypertension was caused or aggravated by the OSA, and the underlying disease remains.

Aggravation of Pre-Existing Hypertension

Some veterans had baseline hypertension before service-connected OSA developed or was diagnosed. In those cases, the secondary nexus letter addresses aggravation — articulating the baseline severity of hypertension, the worsening attributable to the OSA, and the medical reasoning for why the increment exceeds the natural progression.

Indicators of OSA-related aggravation include: development of treatment-resistant hypertension requiring multiple medications, loss of nighttime blood pressure dipping on ambulatory monitoring, escalating doses or new medication classes added in temporal proximity to OSA diagnosis, and signs of end-organ damage developing despite previously stable hypertension.

Evidence Required for the Claim

A defensible hypertension-secondary-to-OSA claim typically rests on the following evidence.

Existing OSA Service Connection

The OSA must be service-connected, typically supported by a sleep study (polysomnography or home sleep apnea test) showing apnea-hypopnea index (AHI) above the diagnostic threshold and a CPAP prescription.

Hypertension Documentation

Sequential blood pressure readings establishing the diagnosis under DC 7101 criteria. Office readings, home monitoring data, or ambulatory blood pressure monitoring.

Medication History

Records of antihypertensive medications prescribed, including dose, duration, and any escalation pattern. The number of medications required reflects severity and treatment resistance.

Temporal Documentation

Records establishing the chronological relationship between OSA diagnosis (or symptom onset) and hypertension diagnosis or worsening.

Cardiology or Sleep Medicine Records

Specialist evaluations characterizing the severity and pattern of hypertension.

Medical Nexus Opinion

A licensed physician's opinion using the "at least as likely as not" standard, articulating the pathophysiologic mechanism and citing relevant clinical literature.

Building the Nexus Letter

A defensible nexus letter for hypertension secondary to OSA contains the following elements.

Identification of the Service-Connected OSA

The letter should reference the existing OSA service connection, including the sleep study findings (AHI, oxygen desaturation), CPAP prescription, and current rating.

Current Hypertension Diagnosis

The letter should identify the hypertension diagnosis with specific blood pressure readings, current medication regimen, and any indicators of severity or treatment resistance.

Pathophysiologic Mechanism

The opinion should articulate the multiple pathways — sympathetic activation, RAAS activation, endothelial dysfunction, vascular remodeling — by which OSA causes or aggravates hypertension. Reference to the AHA/ACC guidelines and the broader clinical literature strengthens the rationale.

Causation or Aggravation Specification

Whether OSA caused new-onset hypertension or aggravated a pre-existing condition. For aggravation, the baseline and increment should be characterized.

"At Least as Likely as Not" Language

The opinion must use the VA's required threshold.

Records-Based Review

The letter should affirm that the physician reviewed the OSA diagnostic records, hypertension treatment records, and medication history before forming the opinion.